With the 2012-2013 influenza season reaching epidemic levels across the U.S., Kimberly-Clark is continuing to increase production of face masks and other personal protective equipment (PPE) products in response to increased customer demand from acute care facilities across the country.
The Centers for Disease Control and Prevention (CDC) reported that the flu season began earlier than usual this year and is shaping up to be more severe than in years past. Kimberly-Clark has been closely monitoring CDC data and adjusting manufacturing schedules and inventory management in anticipation of continued increased demand from current customers for PPE, including face mask products.
The health and safety of our valued customers and their patients is our most important priority, says John Amat, vice president of sales and marketing for Kimberly-Clark Health Care. Kimberly-Clark representatives are proactively reaching out to all of our current customers to assure them that with our North America-based product supply, we can continue to provide the highest quality facial protection products throughout the flu season.Â
To further help customers, their patients and consumers prevent the spread of the flu, Kimberly-Clark recommends these simple prevention precautions:Â
-Â Get vaccinated: The CDC recommends a yearly flu vaccine as the first and most important step in protecting against this serious virus.
-Â Pay attention to hand hygiene: One of the best ways to help prevent the spread of the flu is to wash your hands with soap and water. If soap and water are not available, use an alcohol-based handrub.
-Â Contain the germs: Cover your nose and mouth with a tissue when you cough or sneeze. This will block the spread of droplets from your mouth or nose that could contain germs.
Additional tips and information for patients can be found at: www.preventinfections.com. Kimberly-Clark also offers complimentary, accredited clinical education webinars on the topic of flu via The Kimberly-Clark Knowledge Network at: http://en.haiwatch.com/ClinicalEducation.aspx#5.   Â
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
2 Commerce Drive
Cranbury, NJ 08512